X0202 SCHEDULE 13G 0002080535 XXXXXXXX LIVE Common Stock, $0.01 par value per share 05/11/2026 0001489993 Mobia Medical, Inc. 60705V103 2802 Flintrock Trace Suite 226 Austin TX 78738 Rule 13d-1(c) Synapse Investment, LP DE 0.00 1986072.00 0.00 1986072.00 1986072.00 N 6.0 PN Synapse Investment Partners I, LP DE 0.00 1986072.00 0.00 1986072.00 1986072.00 N 6.0 PN Synapse Investment Partners, LLC DE 0.00 1986072.00 0.00 1986072.00 1986072.00 N 6.0 OO Simeon George X1 0.00 1986072.00 0.00 1986072.00 1986072.00 N 6.0 IN Mobia Medical, Inc. 2802 Flintrock Trace, Suite 226, Austin, TX 78738 Synapse Investment, LP ("Synapse"); Synapse Investment Partners I, LP ("Partners I"); Synapse Investment Partners, LLC ("Partners"); and Simeon George, M.D. ("Dr. George"). Partners I is the general partner of Synapse. Partners is the sole general partner of Partners I. Dr. George is the managing member of Partners. Partners I, Partners, and Dr. George share voting and dispositive power with respect to the securities directly held by Synapse. The persons named in this Item 2(a) are referred to individually herein as a "Reporting Person" and collectively as the "Reporting Persons." The address of the principal business office of each Reporting Person is c/o SR One Capital Management, LP, 929 Main Street, Suite 200, Redwood City, CA 94063. Synapse and Partners I are each limited partnerships organized under the laws of the State of Delaware. Partners is a limited liability company organized under the laws of the State of Delaware. Dr. George is a United States citizen. Y The information in Items 1 and 5 through 11 on the cover page for each Reporting Person of this Schedule 13G is hereby incorporated by reference. See Line 11 of cover sheets. See Line 5 of cover sheets. See Line 6 of cover sheets. See Line 7 of cover sheets. See Line 8 of cover sheets. Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. Exhibit 1 - Agreement regarding filing of joint Schedule 13G. Exhibit 2 - Power of Attorney regarding filings under the Securities Exchange Act of 1934, as amended. Synapse Investment, LP /s/ Sasha Keough 05/18/2026 Synapse Investment Partners I, LP /s/ Sasha Keough 05/18/2026 Synapse Investment Partners, LLC /s/ Sasha Keough 05/18/2026 Simeon George /s/ Sasha Keough 05/18/2026 This Schedule 13G was executed by Sasha Keough on behalf of the individual listed above pursuant to a Power of Attorney, a copy of which is attached as Exhibit 2.